Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (Sterile)

Manufacturer
NuCare Pharmaceuticals,Inc.
Effective date
2017-09-07
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:12:19

Label at a glance#

ProductProparacaine Hydrochloride
Active ingredientPROPARACAINE HYDROCHLORIDE
Label structure12 sections

Indications and uses

Proparacaine hydrochloride ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated; corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies and for short corneal and conjunctival procedures.

Dosage and administration

Usual dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating. Short corneal and conjunctival procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses. NOTE: Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% should be clear, colorless to faint yellow color. If the solution becomes darker, discard the solution. FOR TOP...

Storage and handling

Refrigerate at 2°-8°C (36°- 46°F). Protect from light. Keep tightly closed. DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT. KEEP OUT OF REACH OF CHILDREN. Revised: July 2016 Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA ©Bausch & Lomb Incorporated 9114403 (Folded) 9114503 (Flat)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

DESCRIPTION

DESCRIPTION SECTION

Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% is a topical local anesthetic for ophthalmic use. The active ingredient is represented by the structural formula:

Established name:

Proparacaine Hydrochloride

Chemical name:
Benzoic acid, 3-amino-4-propoxy-,2-(diethylamino) ethyl ester, monohydrochloride

Proparacaine Hydrochloride (structural formula)
Proparacaine Hydrochloride (structural formula)

Molecular weight: 330.85

Each mL contains:

Active: proparacaine hydrochloride 5 mg (0.5%). Inactives: glycerin and purified water. The pH may be adjusted with hydrochloric acid and/or sodium hydroxide. Preservative: benzalkonium chloride (0.01%).

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Proparacaine hydrochloride ophthalmic solution is a rapidly-acting topical anesthetic, with induced anesthesia lasting approximately 10-20 minutes.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Proparacaine hydrochloride ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated; corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies and for short corneal and conjunctival procedures.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Proparacaine hydrochloride ophthalmic solution is contraindicated in patients with known hypersensitivity to any of the ingredients of this preparation.

WARNINGS

WARNINGS SECTION

NOT FOR INJECTION INTO THE EYE - FOR TOPICAL OPHTHALMIC USE ONLY

Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss.

PRECAUTIONS

PRECAUTIONS SECTION

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate carcinogenic potential, mutagenicity or possible impairment of fertility in males or females.

Pregnancy

PREGNANCY SECTION

Pregnancy Category C Animal reproduction studies have not been conducted with Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5%. It is also not known whether proparacaine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine hydrochloride should be administered to a pregnant woman only if clearly needed.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when proparacaine hydrochloride is administered to a nursing woman.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness of proparacaine hydrochloride ophthalmic solution in pediatric patients have been established. Use of proparacaine hydrochloride is supported by evidence from adequate and well-controlled studies in adults and children over the age of twelve, and safety information in neonates and other pediatric patients.

Geriatric Use

GERIATRIC USE SECTION

No overall clinical differences in safety of effectiveness have been observed between the elderly and other adult patients.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Occasional temporary stinging, burning and conjunctival redness may occur with the use of proparacaine. A rare, severe, immediate-type, apparently hyperallergic corneal reaction characterized by acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and sometimes iritis with descemetitis has been reported.

Allergic contact dermatitis from proparacaine with drying and fissuring of the fingertips has been reported.

To report SUSPECTED ADVERSE REACTIONS, contact Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Usual dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating.

Short corneal and conjunctival procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses.

NOTE: Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% should be clear, colorless to faint yellow color. If the solution becomes darker, discard the solution.

FOR TOPICAL OPHTHALMIC USE ONLY

HOW SUPPLIED

HOW SUPPLIED SECTION

Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% is supplied in a plastic bottle with a controlled drop tip and a white polypropylene cap in the following size:

NDC 68071-1332-5 Box of 15mL

Storage

STORAGE AND HANDLING SECTION

Refrigerate at 2°-8°C (36°- 46°F). Protect from light. Keep tightly closed.

DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT.

KEEP OUT OF REACH OF CHILDREN.

Revised: July 2016

Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA

©Bausch & Lomb Incorporated

9114403 (Folded)
9114503 (Flat)

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

pdppdp

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68071-1332-5ML - Milliliter68071-1332753c0df9-95da-41a5-b0f3-6d2f458cd4d712017-09-11
24208-730-06ML - Milliliter24208-7304aacb9e2-351b-4cc5-bfee-c49a6d2147d612012-07-24

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68071-133268071-1332-5
24208-730

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A040074-001PROPARACAINE HYDROCHLORIDEPROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A040074-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-2984e616aacf4f…
2026-08-18 06:07:402026-07A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-2903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-292680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-295bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-2974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-2987673890dc5c…
2021-03-12 10:30 UTC2021-03A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-295aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-298869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-293f01610625f2…
2019-09-15 20:21 UTC2019-09A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29b00525d2431f…
2019-07-19 19:46 UTC2019-07A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-296a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-291c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-299b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-293f0d92c62455…
2023-05-13 08:27 UTC2023-05A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29053a50430f4f…
2023-01-26 05:58 UTC2023-01A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-293bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-293a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A040074-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A040074-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040074-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040074-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A040074-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040074-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040074-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040074-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040074-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040074-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040074-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040074-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040074-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040074-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040074-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040074-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040074-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040074-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040074-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040074-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040074-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040074-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040074-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A040074-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040074-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040074-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040074-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A040074-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A040074-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040074-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040074-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040074-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040074-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040074-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040074-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040074-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A040074-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A040074-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040074-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040074-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Proparacaine HydrochloridePROPARACAINE HYDROCHLORIDEBausch & Lomb Incorporatedb699f838-8b69-4bac-953b-ea8822ec19fc2023-09-01Warnings, Adverse reactionsExact identifier
ndc (product): 24208-730
c018aad4-df25-54b5-e053-2a95a90a6293589ac17c-9400-e481-e053-2991aa0adbb52021-04-16Warnings, Adverse reactionsExact identifier
spl set id: 589ac17c-9400-e481-e053-2991aa0adbb5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.